Title: Risk of Clostridioides difficile infection in inflammatory bowel disease patients
undergoing vedolizumab treatment: a systematic review and meta-analysis
Version: 6 Date: 28 Sep 2024
Reviewer's report:
Authors have succesfully addressed the comments.
Title: Risk of Clostridioides difficile infection in inflammatory bowel disease patients
undergoing vedolizumab treatment: a systematic review and meta-analysis
Version: 6 Date: 28 Sep 2024
Reviewer's report:
Authors have succesfully addressed the comments.
Please review this paper.
user
Title: Risk of Clostridioides difficile infection in inflammatory bowel disease patients
undergoing vedolizumab treatment: a systematic review and meta-analysis
Version: 6 Date: 28 Sep 2024
Reviewer's report:
Authors have succesfully addressed the comments.
assistant